Product
BLI5100
3 clinical trials
2 indications
Indication
Non-erosive Reflux DiseaseIndication
Erosive EsophagitisClinical trial
A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux DiseaseStatus: , Estimated PCD: 2024-03-31
Clinical trial
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux DiseaseStatus: Active (not recruiting), Estimated PCD: 2024-01-26
Clinical trial
A Phase 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive EsophagitisStatus: Recruiting, Estimated PCD: 2024-06-30